News in Brief: DOAC interaction with PPI; COVID-19 vaccine for haemophilia patients; Billion dollar fine for clopidogrel claims

 DOAC failure due to PPI interaction  Doctors are warning clinicians to watch for potential, previously unreported DOAC interactions with PPIs following a case report of sub therapeutic anticoagulation with dabigatran. The latest case, published in a letter to the editor of Internal Medicine Journal, describes an 81-year old male patient on dabigatran for AF. He ...

Already a member?

Login to keep reading.

© 2021 the limbic